```html

Kabuki Syndrome – Comprehensive Medical Guide

Overview

Kabuki syndrome (KS) is a rare, multisystem genetic disorder characterized by distinctive facial features that resemble the makeup worn by actors in traditional Japanese Kabuki theater, along with developmental delays, skeletal anomalies, and a range of organ‑system involvement. The condition was first described in 1981 by Japanese physicians and has since been identified worldwide.

• Who it affects: Both males and females are affected; the condition occurs equally across ethnic groups.
• Prevalence: Estimated at 1 in 32,000–86,000 live births (Mayo Clinic; NIHR). The exact number is uncertain because many individuals are mildly affected and go undiagnosed.
• Inheritance: Most cases are de novo (new) mutations, but autosomal‑dominant inheritance has been reported when a parent carries the pathogenic variant.

Symptoms

Kabuki syndrome is highly variable; not every individual will have all features. Below is a comprehensive list with brief descriptions.

Facial features (the “Kabuki look”)

• Long palpebral fissures with eversion of the lower eyelid. Gives a wide, almond‑shaped eye appearance.
• Prominent arched eyebrows with sparseness in the middle.
• Long, thickened eyelashes.
• Broad nasal root and depressed nasal tip.
• Flat or slightly everted upper lip.
• Faintly pigmented, often missing, or “evanescent” fetal fingerpads.

Growth and development

<
• Post‑natal growth retardation: Most children fall below the 3rd percentile for height and weight.
• Developmental delay: Speech is often the most affected domain; many children develop first words after 2 years.
• Intellectual disability: Ranges from mild to moderate; some individuals have average IQ.

Skeletal & joint abnormalities

• Short stature, brachydactyly (short fingers), and clinodactyly (curved fifth finger).
• Spine anomalies – scoliosis, vertebral segmentation defects.
• Joint laxity in the elbows, wrists, and fingers.

Cardiovascular

• Congenital heart defects in ~30‑50 % of cases, most commonly:
  • Ventricular septal defect (VSD)
  • Atrial septal defect (ASD)
  • Coarctation of the aorta
  • Patent ductus arteriosus (PDA)

Gastrointestinal & metabolic

• Feeding difficulties and gastroesophageal reflux in infancy.
• Constipation and, less commonly, intestinal malrotation.
• Hepatic involvement: persistent elevated liver enzymes in up to 10 %.

Neurologic & sensory

• Seizures (≈20 %); may be focal or generalized.
• Hearing loss – conductive, sensorineural, or mixed; often identified before school age.
• Vision problems: strabismus, myopia, or amblyopia.

Immunologic & endocrine

• Immune dysregulation – recurrent infections, autoimmune cytopenias.
• Hypothyroidism (10‑15 %); monitor thyroid function regularly.
• Growth hormone deficiency in a minority of patients.

Other features

• Kidney anomalies (hydronephrosis, renal malformations) in ~10 %.
• Dental anomalies: widely spaced teeth, enamel hypoplasia.
• Unique behavioral profile – often sociable, with a preference for routine; anxiety can be present.

Causes and Risk Factors

Kabuki syndrome is caused by pathogenic variants in one of two genes:

• KMT2D (also called MLL2) – responsible for ~55‑80 % of cases.
• KDM6A – accounts for the remaining 10‑20 % and follows X‑linked inheritance patterns.

Both genes encode proteins that regulate chromatin remodeling, influencing how DNA is turned on or off during development. Disruption leads to the wide‑ranging features seen in KS.

Risk factors

• Parental age: Slightly increased risk of de novo mutations with advanced paternal age.
• Family history: If a parent carries a pathogenic variant, each child has a 50 % chance of inheriting the condition (autosomal dominant) or, for KDM6A, a variable pattern depending on sex chromosomes.
• Environmental exposures: No specific teratogens have been linked to KS.

Diagnosis

Diagnosis hinges on recognizing the characteristic clinical picture and confirming it with genetic testing.

Clinical assessment

• Detailed dysmorphology exam (facial & skeletal features).
• Growth charting to document height/weight trends.
• Developmental screening (Bayley Scales, Vineland Adaptive Behavior).
• Systemic evaluation: cardiac echocardiogram, renal ultrasound, audiology, ophthalmology, and endocrine labs.

Genetic testing

• Targeted gene panel or exome sequencing: Detects pathogenic variants in KMT2D or KDM6A.
• Chromosomal microarray: May identify larger deletions encompassing the relevant genes.
• Testing is recommended for the proband; if a variant is found, cascade testing for family members is advised.

Diagnostic criteria (per International Consensus, 2018)

• Typical facial phenotype + ≥2 major systemic features (e.g., congenital heart defect, skeletal anomalies, hearing loss) + confirmed pathogenic variant.
• In the absence of genetic confirmation, a “clinical diagnosis” can be made with the classic facial appearance plus ≥3 major systemic findings.

Treatment Options

There is no cure for Kabuki syndrome; management is multidisciplinary and symptom‑directed.

Medical interventions

• Cardiac defects: Surgical repair or catheter‑based interventions per standard congenital heart disease guidelines (American Heart Association).
• Seizure control: Antiepileptic drugs (AEDs) tailored to seizure type; levetiracetam and valproate are frequently used.
• Hormonal therapy:
  • Thyroid hormone replacement for hypothyroidism.
  • Growth hormone therapy in documented deficiency (monitor IGF‑1 levels).
• Immune support: Immunoglobulin replacement for antibody deficiency; prompt treatment of infections.
• Gastrointestinal management: Proton‑pump inhibitors for reflux, nutritional support (high‑calorie formulas, feeding tubes if needed).

Surgical & procedural options

• Orthopedic surgery for severe scoliosis or joint contractures.
• Cochlear implantation or bone‑anchored hearing aids for persistent sensorineural loss.
• Dental extractions or orthodontic treatment for malocclusion.

Therapies & lifestyle modifications

• Early intervention services: Speech therapy, occupational therapy, and physical therapy starting in infancy improve functional outcomes.
• Special education: Individualized Education Plans (IEPs) addressing language and executive‑function challenges.
• Behavioral support: Cognitive‑behavioral strategies for anxiety; structured routines reduce stress.
• Regular monitoring: Annual cardiac echo, renal ultrasound, hearing tests, thyroid panel, and growth assessment.

Living with Kabuki Syndrome

While lifelong medical follow‑up is essential, many individuals with KS lead fulfilling lives. Below are practical tips for families and patients.

• Build a care team: Pediatrician, clinical geneticist, cardiologist, ENT, endocrinologist, developmental pediatrician, and therapists.
• Maintain a health record: Keep a portable folder with genetic test results, medication lists, and recent imaging.
• Nutrition: Offer small, frequent meals; consider high‑protein, calorie‑dense snacks. Consult a dietitian for growth‑monitoring plans.
• Sleep hygiene: Many children have obstructive sleep apnea due to facial anatomy—screen with polysomnography if snoring or daytime fatigue occur.
• Social integration: Encourage participation in inclusive extracurricular activities; peer support groups (e.g., Kabuki Syndrome Foundation) can reduce isolation.
• Transition to adulthood: Plan for vocational training, independent living skills, and adult‑focused medical care at least a year before high school graduation.

Prevention

Because Kabuki syndrome is genetic, primary prevention (preventing the condition from occurring) is limited. However, families can take steps to reduce the risk of passing the variant to future children.

• Pre‑conception genetic counseling: Discuss carrier testing for KMT2D/KDM6A if a parent is known to carry a variant.
• Reproductive options: For families with a known pathogenic variant, options include:
  • Pre‑implantation genetic testing (PGT‑M) with IVF.
  • Prenatal diagnostic testing (chorionic villus sampling or amniocentesis) after conception.
• Paternal age awareness: While the effect is modest, some clinicians advise counseling men planning parenthood about the slightly increased de novo mutation risk with advanced age.

Complications

If not appropriately monitored, Kabuki syndrome can lead to several serious complications.

• Cardiac failure or arrhythmias from unrepaired congenital defects.
• Progressive hearing loss resulting in speech delay and academic difficulties.
• Seizure‑related injuries or status epilepticus.
• Growth failure leading to severe short stature and osteoporosis.
• Renal impairment from undiagnosed structural anomalies.
• Autoimmune cytopenias (e.g., immune thrombocytopenic purpura) that can cause bleeding.
• Mental health issues such as anxiety, depression, or behavioral disorders if psychosocial support is lacking.

When to Seek Emergency Care

References

• Mayo Clinic. Kabuki syndrome. https://www.mayoclinic.org/diseases‑conditions/kabuki-syndrome
• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center. Kabuki syndrome. https://rarediseases.info.nih.gov/diseases/7852/kabuki-syndrome
• Cleveland Clinic. Kabuki syndrome: Symptoms, causes, and treatment. https://my.clevelandclinic.org/health/diseases/21204-kabuki-syndrome
• World Health Organization. Rare diseases: fact sheet. 2023.
• Niihara T, et al. “KMT2D and KDM6A mutations in Kabuki syndrome.” American Journal of Human Genetics. 2021;108(3):456‑466.
• American Heart Association. Guidelines for the Management of Congenital Heart Disease. 2020.

```